Hyaluronic acid-green tea catechin micellar nanocomplexes: Fail-safe cisplatin nanomedicine for the treatment of ovarian cancer without off-target toxicity.

[1]  Stephen J Kron,et al.  Nanoparticle formulations of cisplatin for cancer therapy. , 2016, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[2]  A. J. Tavares,et al.  Analysis of nanoparticle delivery to tumours , 2016 .

[3]  R. Haag,et al.  Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo. , 2016, Biomaterials.

[4]  Yangzhong Liu,et al.  Human Serum Albumin Conjugated Nanoparticles for pH and Redox-Responsive Delivery of a Prodrug of Cisplatin. , 2015, Chemistry.

[5]  M. Jayakannan,et al.  Core-shell polymer nanoparticles for prevention of GSH drug detoxification and cisplatin delivery to breast cancer cells. , 2015, Nanoscale.

[6]  F. Fraternali,et al.  Structural Properties of Green Tea Catechins. , 2015, The journal of physical chemistry. B.

[7]  Xuemin Wang,et al.  EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer , 2015, PloS one.

[8]  Ping Wang,et al.  Mitochondrial Modulation by Epigallocatechin 3-Gallate Ameliorates Cisplatin Induced Renal Injury through Decreasing Oxidative/Nitrative Stress, Inflammation and NF-kB in Mice , 2015, PloS one.

[9]  Yan Gao,et al.  Up-regulation of CD44 in the development of metastasis, recurrence and drug resistance of ovarian cancer , 2015, Oncotarget.

[10]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[11]  William Y. Kim,et al.  Nanoparticles with Precise Ratiometric Co‐Loading and Co‐Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer , 2014, Advanced functional materials.

[12]  R. Sistla,et al.  Ameliorative Effect of Fisetin on Cisplatin-Induced Nephrotoxicity in Rats via Modulation of NF-κB Activation and Antioxidant Defence , 2014, PloS one.

[13]  Hak Soo Choi,et al.  Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy , 2014, Nature nanotechnology.

[14]  D. Oupický,et al.  Opposing influence of intracellular and membrane thiols on the toxicity of reducible polycations. , 2013, Biomaterials.

[15]  T. Minko,et al.  Targeted Nanomedicine for Suppression of CD44 and Simultaneous Cell Death Induction in Ovarian Cancer: An Optimal Delivery of siRNA and Anticancer Drug , 2013, Clinical Cancer Research.

[16]  Arun K Iyer,et al.  Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors. , 2013, Biomaterials.

[17]  C. Landen,et al.  Enhancement of Cisplatin-Mediated Apoptosis in Ovarian Cancer Cells through Potentiating G2/M Arrest and p21 Upregulation by Combinatorial Epigallocatechin Gallate and Sulforaphane , 2013, Journal of oncology.

[18]  A. Pandey,et al.  Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity , 2012, Proceedings of the National Academy of Sciences.

[19]  J. Li,et al.  Drug release from nanomedicines: selection of appropriate encapsulation and release methodology , 2012, Drug Delivery and Translational Research.

[20]  Kwangmeyung Kim,et al.  Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy. , 2011, ACS nano.

[21]  Kenneth P. Nephew,et al.  Rethinking ovarian cancer: recommendations for improving outcomes , 2011, Nature Reviews Cancer.

[22]  H. Salem,et al.  Novel chemotherapeutic and renal protective effects for the green tea (EGCG): role of oxidative stress and inflammatory-cytokine signaling. , 2010, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[23]  E. Lengyel.  Ovarian cancer development and metastasis. , 2010, The American journal of pathology.

[24]  O. Kucuk,et al.  Epigallocatechin-3-gallate activates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. , 2010, Life sciences.

[25]  S. Howell,et al.  CD44-targeted microparticles for delivery of cisplatin to peritoneal metastases. , 2010, Molecular pharmaceutics.

[26]  Michael F. Flessner,et al.  Intraperitoneal therapy for peritoneal tumors: biophysics and clinical evidence , 2010, Nature Reviews Clinical Oncology.

[27]  Liangfang Zhang,et al.  Polymer--cisplatin conjugate nanoparticles for acid-responsive drug delivery. , 2010, ACS nano.

[28]  A. Hoffman,et al.  Target specific and long-acting delivery of protein, peptide, and nucleotide therapeutics using hyaluronic acid derivatives. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[29]  T. Hambley,et al.  Platinum drug distribution in cancer cells and tumors. , 2009, Chemical reviews.

[30]  Yi Lu,et al.  Reversible cell-specific drug delivery with aptamer-functionalized liposomes. , 2009, Angewandte Chemie.

[31]  Xin Wang,et al.  Cancer prevention by tea: animal studies, molecular mechanisms and human relevance , 2009, Nature Reviews Cancer.

[32]  Tae Gwan Park,et al.  Synthesis, characterization, and in vivo diagnostic applications of hyaluronic acid immobilized gold nanoprobes. , 2008, Biomaterials.

[33]  M. Gottesman,et al.  The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy. , 2008, Annual review of pharmacology and toxicology.

[34]  Mohammad Saleem,et al.  Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. , 2006, Cancer research.

[35]  Y. Sugiyama,et al.  Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. , 2003, Cancer research.

[36]  Z. Siddik,et al.  The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats. , 1987, Biochemical pharmacology.

[37]  H. Maeda,et al.  The EPR effect for macromolecular drug delivery to solid tumors: Improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo. , 2013, Advanced drug delivery reviews.

[38]  Ick Chan Kwon,et al.  Self-assembled hyaluronic acid nanoparticles for active tumor targeting. , 2010, Biomaterials.

[39]  P. Devarajan,et al.  Cisplatin nephrotoxicity: molecular mechanisms. , 2003, Cancer therapy.